Bodor Nicholas S. (Gainesville FL) Sloan Kenneth B. (Eudora KS) Pogany Stefano A. (Lawrence KS)
출원인 / 주소
INTERx Research Corporation (Lawrence KS 02)
인용정보
피인용 횟수 :
24인용 특허 :
2
초록▼
Novel, transient prodrug forms of dopa and dopamine have (i) the structural formula (I): [Figure] (I) wherein each R is independently selected from the group consisting of hydrogen, R3-CO- and [Figure] wherein X is O, S or NR6; R1 is hydrogen or -COOR8; R2 is hydrogen or OR; R3 is selected from the
Novel, transient prodrug forms of dopa and dopamine have (i) the structural formula (I): [Figure] (I) wherein each R is independently selected from the group consisting of hydrogen, R3-CO- and [Figure] wherein X is O, S or NR6; R1 is hydrogen or -COOR8; R2 is hydrogen or OR; R3 is selected from the group consisting of straight or branched chain alkyl having from 1 to 20 carbon atoms; aryl having from 6 to 10 carbon atoms; cycloalkyl having from 3 to 8 carbon atoms; alkenyl having from 2 to 20 carbon atoms; cycloalkenyl having from 4 to 8 carbon atoms; alkynyl having from 2 to 20 carbon atoms; aralkyl, alkaryl, aralkenyl, aralkynyl, alkenylaryl, alkynylaryl, loweracyloxyalkyl, and carboxyalkyl, wherein alkyl, aryl, alkenyl and alkynyl are as defined above; saturated or unsaturated monoheterocyclic or polyheterocyclic, or fused heterocyclic, containing from 1 to 3 of any one or more of the hetero atom N, S or O in each heterocyclic ring thereof and each such ring being from 3- to 8-membered; and mono- or poly-substituted derivatives of the above, each of said substituents being selected from the group consisting of lower alkyl, lower alkoxy, lower acyl, lower acyloxy, halo, haloloweralkyl, cyano, lower alkoxycarbonyl, loweralkylthio, amino, nitro, loweralkylamino, diloweralkylamino, carboxyl, carbamyl, loweralkylcarbamyl, diloweralkylcarbamyl and [Figure] wherein R5 is hydrogen or alkyl having from 1 to 10 carbons; R4 is hydrogen, R3, lower acyl, cyano, haloloweralkyl, carbamyl, loweralkylcarbamyl, diloweralkylcarbamyl, -CH2ONO2 and -CH2OCOR3; R6 is hydrogen or lower alkyl; R7 is hydrogen, lower alkyl, COCF3, COOC(CH3)3, COOCH2C6H5, or other N-protective group conventional to amino acid acid chemistry; R8 is hydrogen, benzyl, or other conventional, cleavable carboxyl protective group; with the proviso that at least one R must be R3COXCH(R4)-; (ii) the structural formula (I) wherein at least one R3CO- moiety comprising at least one R group is the residue of any naturally occurring protein amino acid, the residue of any N-substituted naturally occurring amino acid, which N-substituent is lower alkyl or any amino acid protective group cleavable via hydrogenolysis or hydrolysis, or the residue of an N,N-lower dialkyl or C4-C7 cycloalkylamino acid; and (ii) the non-toxic, pharmaceutically acceptable salts thereof.
대표청구항▼
A compound selected from the group consisting of those having (i) the structural formula (I): [Figure] (I) wherein each R is independently selected from the group consisting of hydrogen, R3-CO-and [Figure] wherein X is O, S or NR6; R1 is hydrogen or -COOR8; R2 is hydrogen or OR; R3 is selected from
A compound selected from the group consisting of those having (i) the structural formula (I): [Figure] (I) wherein each R is independently selected from the group consisting of hydrogen, R3-CO-and [Figure] wherein X is O, S or NR6; R1 is hydrogen or -COOR8; R2 is hydrogen or OR; R3 is selected from the group consisting of straight or branched chain alkyl having from 1 to 20 carbon atoms; aryl having from 6 to 10 carbon atoms; cycloalkyl having from 3 to 8 carbon atoms; alkenyl having from 2 to 20 carbon atoms; cycloalkenyl having from 4 to 8 carbon atoms; alkynyl having from 2 to 20 carbon atoms; aralkyl, alkaryl, aralkenyl, aralkynyl, alkenylaryl, alkynylaryl, loweracyloxyalkyl, and carboxyalkyl, wherein alkyl, aryl, alkenyl and alkynyl are as defined above; and mono- or polysubstituted derivatives of the above, each of said substituents being selected from the group consisting of lower alkyl, lower alkoxy, lower acyl, lower acyloxy, halo, haloloweralkyl, cyano, lower alkoxycarbonyl, loweralkylthio, amino, nitro loweralkylamino, diloweralkylamino, carboxyl, carbamyl, loweralkylcarbamyl, diloweralkylcarbamyl and [Figure] wherein R5 is hydrogen or alkyl having from 1 to 10 carbons; R4 is hydrogen, R3, lower acyl, cyano, haloloweralkyl, carbamyl, loweralkylcarbamyl, diloweralkylcarbamyl, -CH2ONO2 and -CH2OCOR3; R6 is hydrogen or lower alkyl; R7 is hydrogen, lower alkyl, COCF3, COOC(CH3)3, COOCH2C6H5, or N-protective group; R8 is hydrogen, benzyl, or carboxyl protective group; with the proviso that at least one R must be R3COXCH(R4)-; and (ii) the non-toxic, pharmaceutically acceptable salts thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (2)
Sundeen ; Joseph E. ; Hauck ; Frederic P., 4,5-Disubstituted-1-aminoalkyl cyclohexenes.
Bodor Nicolae S. (Lawrence KS) Sloan Kenneth B. (Lawrence KS) Hussain Anwar A. (Lexington KS), N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same.
Mao, Chen; Pargaonkar, Nikhil; Maurer, Laura E.; Ma, Sarina Grace Harris, Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.